CH25H and neoplasm: Collectively, these findings indicate that myeloid‐specific knockdown of CH25H blunts tumor growth; however, the reintroduction of 25HC or the administration of the STING inhibitor C176 can reverse this effect, thereby accelerating tumorigenesis and progression.